World of DTC Marketing

JUNE 1, 2021

With a lot of money pouring in from MS drugs, their CEO decided that they needed to act like big pharma and moved the company to downtown Cambridge under the guise that it was necessary to get closer to biomedical R&D. If the drug is approved you can bet that it’s going to carry a huge price tag.

Drugs 187

Drugs Trials Doctors Doctor 187

World of DTC Marketing

SEPTEMBER 24, 2021

Then they decided to move their HQ to an expensive campus in downtown Cambridge to play with “big pharma” Along with the move came new competitors and MS patients who reported that other MS drugs were better. I remember when Biogen was an exciting new biotech based in Westin.

Drugs 222

Drugs Pharma Companies Doctors Doctor 222

Drug Discovery World

NOVEMBER 28, 2023

The peer-reviewed article titled ‘Knockout or inhibition of USP30 protects dopaminergic neurons in a Parkinson’s disease (PD) mouse model’ was the result of collaborative work between Cambridge University, Harvard Medical School, and Mission Therapeutics.

In-Vivo 52

In-Vivo Protein Drugs Research 52

pharmaphorum

APRIL 26, 2021

In 2019 Cognitant and Addenbrook’s Hospital in Cambridge, UK piloted a programme that aimed to educate patients to improve adherence to rheumatoid arthritis medicines. It comprises more than 170 companies and employs 20,000 people across 20 countries worldwide.

Development 121

Development Medicine Production Marketing 121

Delveinsight

FEBRUARY 25, 2021

Cambridge, Massachusetts-based Beam aims to make more precise edits with genetic medicines, which employ base-editing. DNA hypomethylating agents are epigenetic drugs that eliminate specific chemical tags on DNA, hence turning specific genes on and off and changing the cells’ function.

DNA 52

DNA In-Vivo Genetics Medicine 52

Intouch Solutions

AUGUST 25, 2021

Sessions and panels at SXSW have changed from “User Privacy in a Post Cambridge Analytica World” to “Forging a New Social Contract for Big Tech” and “Building Digital Trust in a Transformed World.” ©Intouch Group 2021. Author : Devon Cross, Director, CX Strategy Consulting Partners: Julia Osmond, Sr. Want to learn more?

Marketing 52

Marketing Regulation Engineer Branding 52

XTalks

AUGUST 17, 2020

Cue Biopharma is a Cambridge, Massachusetts-based clinical-stage biotechnology company that is focused on developing injectable immune biologics using its proprietary Immuno-STAT (Selective Targeting and Alteration of T cells) platform. “The

Protein 98

Protein Engineer Immune Response In-Vivo 98